New combo pill tested in healthy volunteers – no cure, just data
Knowledge-focused
Completed
This study tested a new drug called HD-P023 in 40 healthy adults to see how it compares to taking two diabetes medicines (teneligliptin and empagliflozin) together. The goal was to measure how the body absorbs and processes the drugs, not to treat any disease. Participants were h…
Phase: PHASE1 • Sponsor: Handok Inc. • Aim: Knowledge-focused
Last updated Jun 05, 2026 12:05 UTC